HIT Consultant May 25, 2022
Fred Pennic

What You Should Know:

Pleno, a multi-omics startup, is emerging out of stealth with a $15M Pre-Series A financing and Greg Lucier as Chairman of the Board of Directors. Founded by Pieter van Rooyen, a well-known biotech engineer who built and sold his last company, Edico Genome, to Illumina for $100M. Edico’s Dragen technology has become a staple in genetics research.

– Pleno’s Hypercoding technology has the potential to revolutionize biological target detection for clinical testing and biomedical research. This technology enables the simultaneous and rapid detection of more targets, from more samples at a dramatically lower cost, which has the potential to democratize clinical multi-omics and ultimately transform human health globally.

The World’s First HypercodingTM Instrument...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article